Ainos, Inc.

AIMD

$1.59

+1.92%

N/A+$0.03

Healthcare

Biotechnology

NASDAQ

Active Trading

Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease ...

Recent News of AIMD

Accesswire8/19/2026Neutral

Ainos Launches Atmosphere Engine, Extending Physical AI from Environmental Sensing to Active Environmental Management

High-efficiency, on-site nitrogen generation is designed to protect high-value AI infrastructure, reduce oxidation and environmental degradation, and bring greater flexibility and resilience to semiconductor manufacturing HOUSTON, TX / ACCESS Newswire / August 19, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced the global launch of Atmosphere Engine™ , a new platform that extends the Company's capabilities in AI-powered environmental sensing, Chemical Intelligence and smart manufacturing into active environmental management. Atmosphere Engine is designed to generate high-purity nitrogen and oxygen directly from ambient air, on-site and closer to the point of use.

Accesswire8/17/2026Neutral

Ainos Unveils Next-Generation AI Nose, Advancing the Infrastructure for Chemical Intelligence

Second-generation platform combines upgraded software, firmware, Edge AI and industrial-grade hardware to support reliable 24/7 real-world deployment More than 878 million real-world smell data records strengthen Ainos' Smell Intelligence foundation, with every AI Nose serving as a continuously learning node toward a broader Chemical Intelligence network HOUSTON, TX / ACCESS Newswire / August 17, 2026 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered Chemical Intelligence, today announced the next generation of its AI Nose platform, featuring comprehensive upgrades across software, firmware, edge computing and hardware reliability. The second-generation AI Nose is engineered for continuous, real-world deployment and represents an important step in Ainos' evolution from standalone smell sensing toward a distributed Chemical Intelligence infrastructure for Physical AI.

Accesswire8/13/2026Neutral

Ainos Surpasses 878 Million Real-World Data Points, Up 43% in 23 Days as 1,400-System AI Nose Semiconductor Deployment Advances

Dataset expands by approximately 265 million data points since July 21 as continued AI Nose system deployment across semiconductor manufacturing environments accelerates Ainos' Real-World Data Flywheel and Chemical Intelligence development HOUSTON, TX / ACCESS Newswire / August 13, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that its AI Nose platform has surpassed 878 million real-world smell and chemical data points, primarily generated from semiconductor manufacturing and real-world operating environments, marking another significant milestone in the Company's development of Chemical Intelligence for Physical AI. Since reporting approximately 613 million data points on July 21, 2026, Ainos' dataset has expanded to approximately 878 million data points, adding approximately 265 million data points in just 23 days, an increase of approximately 43%.

Accesswire8/12/2026Neutral

Ainos to Showcase Environmental Intelligence for Physical AI at SEMICON Taiwan 2026

AI Nose and Atmosphere Engine bring a new layer of environmental perception to intelligent machines HOUSTON, TX / ACCESS Newswire / August 12, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it will showcase its Environmental Intelligence solutions for Physical AI at SEMICON Taiwan 2026, taking place September 2-4. Through AI Nose and Atmosphere Engine, Ainos will demonstrate how Environmental Intelligence can give machines a new way to sense, understand, and ultimately respond to the world around them.

Accesswire8/10/2026Neutral

VASRO Research Highlights Ainos' Progress in Scaling Smell AI Commercialization and Compounding Its Smell ID Dataset

HOUSTON, TX / ACCESS Newswire / August 10, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced VASRO GmbH has published a new report discussing Ainos' progress in scaling its AI Nose platform through semiconductor deployments, real-world data accumulation, and commercialization opportunities into the second half of 2026. VASRO notes that AI Nose has accumulated approximately 613 million industrial Smell ID data records since December 2025, primarily from semiconductor manufacturing environments.

Accesswire•8/19/2026

Ainos Launches Atmosphere Engine, Extending Physical AI from Environmental Sensing to Active Environmental Management

Ainos Unveils Next-Generation AI Nose, Advancing the Infrastructure for Chemical Intelligence

Ainos Surpasses 878 Million Real-World Data Points, Up 43% in 23 Days as 1,400-System AI Nose Semiconductor Deployment Advances

Ainos to Showcase Environmental Intelligence for Physical AI at SEMICON Taiwan 2026

VASRO Research Highlights Ainos' Progress in Scaling Smell AI Commercialization and Compounding Its Smell ID Dataset

Zacks Small-Cap Research Covers Ainos' AI Nose Platform and Expansion of Smell AI Applications

HOUSTON, TX / ACCESS Newswire / August 6, 2026 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos" or the "Company") today announced that Zacks Small-Cap Research ("Zacks SCR") has published a research report covering Ainos' AI Nose platform and the Company's efforts to develop digital scent intelligence for artificial intelligence applications. The report discusses Ainos' approach to converting airborne chemical signals into structured digital scent data through AI Nose, Smell ID, and the Company's developing Smell Language Model ("SLM").

Ainos Reports Second Quarter 2026 Results and Highlights Continued AI Nose Execution Across Industrial, Healthcare Infrastructure and Robotics Markets

HOUSTON, TX / ACCESS Newswire / August 3, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced results for the second quarter ended June 30, 2026, and provided a business update on continued execution progress for AI Nose across semiconductor manufacturing, industrial infrastructure, robotics, and healthcare-related environments. Eddy Tsai, Chairman, President and Chief Executive Officer, commented: "We believe AI is increasingly expanding beyond understanding text, images, and speech toward interpreting real-world environmental information.

Ainos Expands Smell AI With Growing Real-World Scent Dataset for Physical AI

AI Nose deployments have generated approximately 613 million industrial scent data points since December 2025, advancing Ainos' vision of a smell intelligence network HOUSTON, TX / ACCESS Newswire / July 21, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer in Smell AI, today announced that its AI Nose deployments have generated approximately 613 million industrial scent data points since December 2025, primarily from semiconductor manufacturing environments. The milestone reflects the continued expansion of Ainos' Smell AI platform.

VASRO Research Highlights Ainos' Expansion of Smell AI Into Patient-Level Breath Intelligence

HOUSTON, TX / ACCESS Newswire / June 22, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a Smell AI company digitizing scent into machine-readable data for artificial intelligence applications, today highlighted a new update report published by VASRO GmbH ("VASRO") reviewing Ainos' planned expansion of its AI Nose platform into patient-level breath intelligence. The VASRO update reviews Ainos' recently announced one-year research program with National Taiwan University, scheduled to begin on July 1, 2026, to evaluate whether AI-analyzed breath patterns may help distinguish acute exacerbations of chronic obstructive pulmonary disease ("COPD") from acute decompensated heart failure among patients presenting with shortness of breath.

Ainos Expands Smell AI Platform into Digital Breath Intelligence Through National Taiwan University Research Program

Program expands Ainos' Smell AI platform from environmental intelligence into digital breath intelligence for emergency medicine research HOUSTON, TX / ACCESS Newswire / June 17, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered scent digitization and Smell AI technologies, today announced a new research program with National Taiwan University ("NTU") to explore the use of Smell AI in emergency medicine. The program, titled "Rapid Diagnosis of Dyspneic Patients in the Emergency Department via AI-powered Electronic Nose Technology," will explore the use of Ainos' Smell AI platform to analyze volatile organic compounds ("VOCs") in exhaled breath.

Ainos Releases 2026 Mid-Year CEO Letter to Shareholders

Building the Olfactory Layer of Physical AI Highlighting Progress Across Semiconductor Manufacturing, Healthcare Infrastructure and Physical AI Applications HOUSTON, TX / ACCESS Newswire / June 8, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered scent digitization and Smell AI technologies, today released its 2026 Mid-Year Letter to Shareholders from Chairman, President and Chief Executive Officer Eddy Tsai. 2026 First Half Highlights Commercial Momentum Reported 499% year-over-year revenue growth during fiscal year 2025.

VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations

HOUSTON, TX / ACCESS Newswire / June 5, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a Smell AI company digitizing scent into machine-readable data for artificial intelligence applications, today highlighted a recent report published by VASRO GmbH ("VASRO"), discussing the expansion of the Company's AI Nose platform into emergency department operations and the continued growth of its Smell ID data across diverse real-world environments. In the report, VASRO reviews Ainos' recently announced research program at one of Asia's leading academic medical centers, where AI Nose is being deployed within a live emergency department environment to evaluate environmental scent analysis for emergency department overcrowding early warning and respiratory infection risk analysis.

Zacks SCR Discusses Ainos' Expansion of Smell AI into Healthcare Infrastructure Through NTUH Study

HOUSTON, TX / ACCESS Newswire / June 3, 2026 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos" or the "Company"), a Smell AI company digitizing scent into machine-readable data for artificial intelligence applications, today announced that Zacks Small-Cap Research ("Zacks SCR") has published a new article discussing Ainos' recently announced healthcare infrastructure study at National Taiwan University Hospital ("NTUH"). The article reviews Ainos' initiative to deploy AI Nose in a live emergency department environment and explores the potential role of Smell AI in environmental monitoring, healthcare infrastructure, and artificial intelligence applications.

Ainos Launches Smell AI Study at National Taiwan University Hospital for ER Overcrowding and Respiratory Infection Risk Analysis

AI Nose Expands from Semiconductor Facilities into Frontline Healthcare Infrastructure HOUSTON, TX / ACCESS Newswire / June 1, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a Smell AI company digitizing scent into machine-readable data for artificial intelligence applications, today announced the launch of a research program at National Taiwan University Hospital ("NTUH"), one of Asia's leading academic medical centers, to deploy AI Nose inside a live emergency department environment for intelligent environmental monitoring, ER overcrowding early warning, and respiratory infection risk analysis. The program aims to expand Smell AI, powered by AI Nose, inside a real-world emergency department environment and expands market opportunities beyond semiconductor and industrial environments into frontline healthcare infrastructure.

Neutral

General

AIMD: Neutral

Supply Chain of AIMD

RELATIONS

Upstream

Taiwan Tanabe Seiyaku Co., Ltd. (subsidiary of Tanabe Pharma Corp)Unnamed Electronic Component / Gas Sensor Suppliers

Downstream

ASE Technology Holding Co., Ltd.NYSE:ASXTopco Scientific Co., Ltd.TWSE:5434Trusval Technology Co., Ltd.TPEX:6667Solomon Technology CorporationTWSE:2359NEXCOM International Co., Ltd.TPEX:8234Kenmec Mechanical Engineering Co., Ltd.TPEX:6125Mirle Automation CorporationTWSE:2464ugo Inc.Taiwan Tanabe Seiyaku Co., Ltd. (subsidiary of Tanabe Pharma Corp)

Proxies

Topco Scientific Co., Ltd.TWSE:5434ASE Technology Holding Co., Ltd.NYSE:ASXSolomon Technology CorporationTWSE:2359Tanabe Pharma CorporationUnconfirmed

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer